Louis Chen's Stock Ratings

Cantor Fitzgerald Analyst

Louis Chen is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/02/2025

Overall Average Return

-64.0%

Smart Score

19%

Overall Average Return Percentile

1st

Number of Ratings

13
Buy NowGet Alert
09/10/2024CATXBuy Now
Perspective Therapeutics
$2.07
Louis Chen19%
Reiterates → OverweightGet Alert
09/09/2024CATXBuy Now
Perspective Therapeutics
$2.07
Louis Chen19%
Reiterates → OverweightGet Alert
09/06/2024CATXBuy Now
Perspective Therapeutics
$2.07
Louis Chen19%
Reiterates → OverweightGet Alert
09/03/2024CATXBuy Now
Perspective Therapeutics
$2.07
Louis Chen19%
Reiterates → OverweightGet Alert
06/25/2024CATXBuy Now
Perspective Therapeutics
$2.07
Louis Chen19%
Reiterates → OverweightGet Alert
06/20/2024CATXBuy Now
Perspective Therapeutics
$2.07
Louis Chen19%
Reiterates → OverweightGet Alert
06/18/2024CATXBuy Now
Perspective Therapeutics
$2.07
Louis Chen19%
Reiterates → OverweightGet Alert
05/09/2024CATXBuy Now
Perspective Therapeutics
$2.07
Louis Chen19%
Initiates → OverweightGet Alert
07/13/2023THTXBuy Now
Theratechnologies
$1.39547.48%
Louis Chen19%
→ $36ReiteratesOverweight → OverweightGet Alert
11/17/2022THTXBuy Now
Theratechnologies
$1.39547.48%
Louis Chen19%
→ $36Initiates → OverweightGet Alert
11/17/2022KMPHBuy Now
KemPharm
Louis Chen19%
→ $20Initiates → OverweightGet Alert
08/23/2022AERIBuy Now
Aerie Pharmaceuticals
Louis Chen19%
$30 → $15.25DowngradeOverweight → NeutralGet Alert
02/24/2022PCVXBuy Now
Vaxcyte
$32.7068.2%
Louis Chen19%
→ $55ReiteratesOverweight → OverweightGet Alert